Harmony Biosciences Holdings, Inc.

US$33.11As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:HRMYHealthcare
Country USA
PE (Fwd) •••
TSR 6Y CAGR (1.08%)
Div yield —
ROE 18.73%
Biotechnology
Beta (5Y) 0.98
PE TTM 10.95
TSR TTM 15.89%
Mkt cap US$1.944B
ROIC 35.49%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$35
6.85%
(77.68%)
Hold 10|11|3|2|9
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.34
0.36
0.37
0.37
12.91%
21.72%
14.19%
19.44%
Revenue$M
84.08
85.31
87.34
92.53
1.76%
0.43%
3.07%
10.24%
Peers (US$1.944B)
Cap (US$)
PE
1.944B
72.40x
Capital
TTM
5Y
10Y
Leveragex
0.144
(0.016)
(0.013)
EBIT/Intx
1.060
0.031
0.037
Own earn%
16.87
212.92
166.78
Sh yield%
47.70
62.26
57.14
Owners
Insiders/Inst%
12.78
89.67
Short interest%
0.77
SBC / revenue%
1.16
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
7
Op margin range%
19–25
$1 testx
—
Incr. ROIC%
15